Palvella Therapeutics (PVLA) Receivables - Other (2014 - 2024)
Palvella Therapeutics (PVLA) posted quarterly Receivables - Other of $506000.0 for Q3 2024, up 269.34% quarter-over-quarter from $137000.0 in Q2 2024.
Palvella Therapeutics (PVLA) Receivables - Other (2014 - 2024) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Receivables - Other for 4 consecutive years, with $506000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Receivables - Other changed N/A year-over-year to $506000.0; the TTM figure through Sep 2024 stood at $506000.0 (changed N/A YoY), while the FY2023 annual figure was $2.3 million, up 403.46% from the prior year.
- Receivables - Other advanced to $506000.0 in Q3 2024 per PVLA's latest filing, from $137000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.3 million in Q1 2024 and bottomed at $137000.0 in Q2 2024.
- Historically, Receivables - Other has averaged $1.2 million across 3 years, with a median of $506000.0 in 2024.
- On a YoY basis, Receivables - Other climbed as much as 403.46% in 2023 and fell as far as 403.46% in 2023.
- Palvella Therapeutics' Receivables - Other stood at $462000.0 in 2022, then surged by 403.46% to $2.3 million in 2023, then plunged by 78.25% to $506000.0 in 2024.
- Business Quant data shows PVLA's Receivables - Other at $506000.0 in Q3 2024, $137000.0 in Q2 2024, and $2.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 506,000.00 |
| Sep 30, 2024 | 506,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 462,000.00 |
| Dec 31, 2022 | 462,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Dec 31, 2014 | 300,000.00 |